Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol Myers Squibb adds structurally diverse compounds to BET inhibitor candidates

Nov. 23, 2021

PTSD model developed in Jeju minipig

Nov. 23, 2021

Novel mouse model of focal limbic seizures with impaired behavior

Nov. 23, 2021

New kappa-opioid receptor agonists discovered at Medshine Discovery

Nov. 23, 2021

Jiangsu Hengrui Medicine and collaborators patent inositol derivatives

Nov. 23, 2021

BeiGene describes BTK-targeting PROTACs

Nov. 23, 2021

Iomx Therapeutics divulges new SIK2/SIK3 inhibitors

Nov. 23, 2021

New antibacterials identified at Roche

Nov. 23, 2021

B-cell GABA release blunts tumor immune response

Nov. 23, 2021

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

Nov. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...